With increased stability, oral preparations also have extended durations of action, further increasing their therapeutic potential [9, 10, 11, 12]
We guarantee a minimum of 99% purity across our entire peptide range
(PubMed) Henkin RI, Patten BM, Re PK, Bronzert DA
10.1038/nmeth.4593 Nat
Cagrilintide is an investigational long-acting amylin analog and is not approved by the FDA, EMA, or any comparable regulator for the treatment, cure, or prevention of obesity, type 2 diabetes, gastrointestinal disorders, or any other condition
GHK-Cu has stronger evidence in dermal and cosmetic applications, including small human studies demonstrating improvements in skin thickness, density, elasticity, and wrinkle reduction after topical application